An official website of the United States government
          Here’s how you know
        Here’s how you know**Official websites use .gov**A
              **.gov** website belongs to an official government
              organization in the United States.
        **Secure .gov websites use HTTPS**A
              **lock** (
              Locked padlock icon) or **https://** means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.
 Top Utility Nav
        
        
        Asian-Language Resources
        
        Portal en español


Site search Mega Menu
  

        

        Home
                  Health Topics
                                      
    
  Health Topics

    Arthritis and Rheumatic Diseases
          
    Muscle and Bone Diseases
          
    Skin Diseases
          
    All Diseases and Conditions
          
    Publication Catalog
                  Grants & Funding
                                      
    
  Grants & Funding

    Current Funding Opportunities
          
    Supported Scientific Programs
          
    NIAMS-Supported Programs
          
    Applying for a Grant
          
    NIH Policies and Guidance
          
    Peer Review and Grants Administration Resources
          
    Types of Funding Mechanisms (Activity Codes)
                  Labs @ NIAMS
                                      
    
  Labs @ NIAMS

    NIAMS Labs and Core Facilities
          
    Research Faculty
          
    Research Areas
          
    NIAMS Scientific Advances
          
    Training and Career Development
                  Clinical Trials
                                      
    
  Clinical Trials
      
            For Principal Investigators

    Clinical Trial Policies, Guidelines, and Templates
          
    Conducting Clinical Trials
          
    Register with ClinicalTrials.gov

For Patients

What is a Clinical Trial?
	Clinical Trials at NIAMS
	Clinical Trials in the Spotlight
                  News & Events
                                      
    
  Newsroom

    All NIAMS News
          
    NIAMS Newsletters
          
    Meetings & Events
                  About NIAMS
                                      
    
  About NIAMS

    Director's Page
          
    NIAMS Organization
          
    Strategic Plan Fiscal Years 2020-2024
          
    Staff Directory
          
    NIAMS Budget
          
    Partnerships
          
    Contact NIAMS
                  Community Outreach
                                      
    
  Community Outreach

    Bone Health
          
    Joint Health
          
    Muscle, Tendon, and Ligament Health
          
    Skin Health
          
    Health Information For Kids And Young Adults
          
    Health Information For Older Adults/Seniors
          
    Printable Materials for Community Events
          
    Resources in Other Languages
          
    Annual Health Observances
          
    Social Media Resources Breadcrumb
    Home
          About NIAMS
          Jin Kyun Park, M.D., Ph.D.





Jin Kyun Park, M.D., Ph.D.


Postdoctoral Fellow
    Vasculitis Translational Research Program Image
              Headshot of a young man with short hair. 
            Contact Information

                                
                                                10 Center Drive
                  
            Building 10, Room 13C210
      
                  
                                   Bethesda MD 20892
                
                                                Parkj30@nih.gov 
                Summary
          Jin Kyun Park, M.D., Ph.D., received his medical degree from Heidelberg University in Germany. He pursued a two-year postdoctoral study in Immunology at Mayo Clinic in Rochester, MN, and then Emory University in Atlanta, GA, focusing on the role of T cell senescence in acute coronary syndrome. After completing his internship and residency in internal medicine at the University of Florida and a clinical fellowship in rheumatology at Johns Hopkins University, he joined the faculty in the Division of Rheumatology at Seoul National University, Korea.He joined the Vasculitis Translational Research Program at NIAMS under Dr. Peter Grayson as a special volunteer to study the immunopathogenesis of large vessel vasculitis.His current research focuses on understanding the link between cancer, infection, and rheumatic diseases. He has developed an interest in inflammatory and non-inflammatory vasculopathy associated with rheumatic connective tissue diseases. In addition, he is actively involved in numerous clinical studies in rheumatoid arthritis, systemic lupus erythematosus, and myositis.In the last few years, he has contributed to several landmark vaccination trials in patients with rheumatic diseases. The findings helped inform in the current vaccination guidelines.
        
                  Research Statement
          
            Dr. Park is actively researching the role of interleukin-6 receptor polymorphism in the pathogenesis and treatment response of giant cell arteritis. Additionally, he conducts studies on the contribution of individual immune cells to vasculitis within a spatial context, employing spatial transcriptome analysis.Furthermore, he focuses on ongoing investigations into vaccine response among patients with rheumatic diseases with a particular emphasis on understanding how immunosuppressants may impact vaccine effectiveness. 

            Scientific Publications
              Effect of the methotrexate discontinuation for 1 versus 2 weeks on vaccine response to seasonal influenza vaccine in rheumatoid arthritis: a noninferiority randomized controlled trial.

    Park JK, Lee YJ, Kang EH, Shin K, Kim MJ, Ha YJ, Choi SR, Park JW, Kim MH, Kim JY, Jung JI, Choi Y, Winthrop KL, Lee EB
        

                    Arthritis Rheumatol.
        
                    2023 Jul 6;
        
        
                    doi: 10.1002/art.42644
                            PMID: 37410775
  Increased risk of congenital malformations in offspring born to women with systemic lupus erythematosus in South Korea: a nationwide population-based study.

    Jung YM, Park JK, Oh MJ, Park CW, Park JS, Jun JK, Lee SM, Cho GJ
        

                    RMD Open.
        
                    2023 Jun;
        
                    9(2).
        
                    doi: 10.1136/rmdopen-2022-002916
                            PMID: 37270202
  Reliability and validity of PROMIS physical function, pain interference, and fatigue as patient reported outcome measures in adult idiopathic inflammatory myopathies: International study from the OMERACT myositis working group.

    DiRenzo D, Saygin D, de Groot I, Bingham Iii CO, Lundberg IE, Needham M, Park JK, Regardt M, Sarver C, Song YW, Maxwell L, Beaton D, de Visser M, Christopher-Stine L, Mecoli CA, Alexanderson H
        

                    Semin Arthritis Rheum.
        
                    2023 Feb;
        
                    58().
        
                    doi: 10.1016/j.semarthrit.2022.152111
                            PMID: 36410180
  A Multicenter, Prospective, Randomized, Parallel-Group Trial on the Effects of Temporary Methotrexate Discontinuation for One Week Versus Two Weeks on Seasonal Influenza Vaccination in Patients With Rheumatoid Arthritis.

    Park JK, Lee YJ, Shin K, Kang EH, Ha YJ, Park JW, Kim MJ, Kim MH, Choi SR, Jung Y, Lee JH, In Jung J, Kim JY, Winthrop KL, Lee EB
        

                    Arthritis Rheumatol.
        
                    2023 Feb;
        
                    75(2).
        
                    doi: 10.1002/art.42318
                            PMID: 35930728
  Proliferative Vasculopathy Associated With Antiphospholipid Antibodies in Patients With Neurological Symptoms.

    Yeo J, Hwang I, Sohn CH, Lee EE, Lee ST, Lee EB, Park JK
        

                    Front Med (Lausanne).
        
                    2022;
        
                    9().
        
                    doi: 10.3389/fmed.2022.913203
                            PMID: 35795628
  Angiographic characteristics of vasculopathy in patients with idiopathic inflammatory myopathies and systemic sclerosis.

    Yeo J, Park EA, Lee EB, Park JK
        

                    Sci Rep.
        
                    2022 May 31;
        
                    12(1).
        
                    doi: 10.1038/s41598-022-12991-y
                            PMID: 35641535 
          Education
              
            **Department of Molecular Medicine and Biopharmaceutical Science, The Graduate School, Seoul National University, Seoul, Korea** Ph.D. (2018)**Ruprecht-Karls University of Heidelberg, Medical Faculty, Heidelberg, Germany** M.D. (2003)             
                        Experience
              
            **Postdoctoral Fellowship**National Institutes of Health, NIAMS (2023 - present)**Rheumatology Division**Seoul National University Hospital, Seoul, Korea (2012- present)**Rheumatology Fellowship**Johns Hopkins University, Baltimore, MD, USA (2008-2012)**Residency Training**University of Florida, Gainesville, FL, USA (2008-2008)**Postdoctoral Fellowship**Lowance Center for Human Immunology, Emory University, Atlanta, GA, (2004-2005)**Postdoctoral Fellowship**College of Medicine, Mayo Clinic, Rochester, MN, USA (2003)


Last Updated: September 2023


Back to Top
 About NIAMS
                    Clinical Trials
                    Grants & Funding
                    Health Topics
                    Labs @ NIAMS
              News Room
                    NIAMS Multimedia Library
                    Disclaimer
                    FOIA
                    Contact us
              Privacy Statement
                    Accessibility
                    HHS Vulnerability Disclosure
                    Social Media Moderation Policy
                    NIAMS Archives
        Subscribe to Our E-Newsletters
            Click the button to see different options to sign up for newsletters.
            Click Here to Subscribe
          Follow us on
  
  About NIH
                  Accessibility Support
            FOIA requests
                  No FEAR Act data
            Office of the Inspector General
                  Performance reports
            Privacy Policy